SG3 Management’s CVS Health CVS Stock Holding History

SG3 Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,500	Closed	-$258K	–	1058
2021 Q4	$258K	Hold	2,500	–	–	0.01%	768
2021 Q3	$212K	Sell	2,500 -11,100	-82%	-$930K	0.01%	764
2021 Q2	$1.14M	Sell	13,600 -32,500	-70%	-$2.66M	0.04%	444
2021 Q1	$3.47M	Sell	46,100 -24,100	-34%	-$1.76M	0.09%	265
2020 Q4	$4.79M	Sell	70,200 -38,300	-35%	-$2.49M	0.09%	206
2020 Q3	$6.34M	Buy	108,500 +38,500	+55%	+$2.4M	0.23%	102
2020 Q2	$4.55M	Buy	+70,000	New	+$4.41M	0.31%	73
2019 Q3	–	Sell	-20,000	Closed	-$1.09M	–	358
2019 Q2	$1.09M	Hold	20,000	–	–	0.12%	149
2019 Q1	$1.08M	Buy	+20,000	New	+$1.23M	0.11%	140
2018 Q3	–	Sell	-100,000	Closed	-$6.43M	–	158
2018 Q2	$6.43M	Buy	+100,000	New	+$6.59M	1.47%	26

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SG3 Management's CVS Position: Q1 2021 in Review

SG3 Management sold out of CVS Health (CVS) in Q1 2021, closing a stake of 15,500 shares — an estimated $1.13M sold.

SG3 Management first reported a position in CVS in Q2 2018 and held it in 7 quarters. The position peaked at $1.06M in Q4 2020. 2,032 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

SG3 Management reported no remaining CVS Health position as of Q1 2021 after selling out during the quarter.
SG3 Management sold 15,500 CVS Health shares in Q1 2021, an estimated $1.13M.
SG3 Management first reported a position in CVS Health in Q2 2018 and held it in 7 quarters.
SG3 Management's CVS Health position peaked at $1.06M in Q4 2020.
2,032 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.